MILTEFOSINE | MILTEFOSINE | ATC P01CX04
ANTIPARASITIC TREATMENT OF LEISHMANIASIS INTERACTION WITH LIPIDS (PHOSPHOLIPIDS AND STEROLS) INHIBITION OF CYTOCHROME C OXIDASE APOPTOSIS-LIKE CELL DEATH | ORAL | Cmax 162.2 MICROMOLAR Tmax 7 HOUR PPB 98 PERCENT HT 153.6 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | MEMBRANE | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |